Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Rheumatol. doi: /nrrheum

Published byЖивојин Васиљевић Modified over 5 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Rheumatol. doi: /nrrheum"— Presentation transcript:

1 Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2015.132
Figure 1 Allopurinol hypersensitivity includes MPE, AHS and allopurinol-induced SCAR Figure 1 | Allopurinol hypersensitivity includes MPE, AHS and allopurinol-induced SCAR. AHS and allopurinol-induced SCAR overlap considerably. Allopurinol-induced SCAR includes SJS/TEN and DRESS. The size of the circles in this figure in no way relate to the frequency of these adverse reactions. Abbreviations: AHS, allopurinol hypersensitivity syndrome; DRESS, drug reaction with eosinophilia and systemic symptoms; MPE, maculopapular eruption; SCAR, severe cutaneous adverse reactions; SJS, Stevens–Johnson syndrome; TEN, toxic epidermal necrolysis. Stamp, L. K. et al. (2015) Allopurinol hypersensitivity: investigating the cause and minimizing the risk Nat. Rev. Rheumatol. doi: /nrrheum

Download ppt "Nat. Rev. Rheumatol. doi: /nrrheum"

Similar presentations

Drug Hypersensitivity with Eosinophilia and Systemic Symptoms

Drug Hypersensitivity with Eosinophilia and Systemic Symptoms
Rapid and Reliable Genotyping of HLA-B*58:01 in Four Chinese Populations Using a Single-tube Duplex Real-time PCR assay Huijuan Wang, Ph.D The National.

Rapid and Reliable Genotyping of HLA-B*58:01 in Four Chinese Populations Using a Single-tube Duplex Real-time PCR assay Huijuan Wang, Ph.D The National.
Author: Sebabatso C. Mthakathi Presenter: Lineo Maja Faculty of Health Sciences Department of Pharmacy.

Author: Sebabatso C. Mthakathi Presenter: Lineo Maja Faculty of Health Sciences Department of Pharmacy.
Title: Use of Topical Cyclosporine 0

Title: Use of Topical Cyclosporine 0
Drug Eruptions Dr sami billal Md.

Drug Eruptions Dr sami billal Md.
OBJECTIVES and METHODOLOGY

OBJECTIVES and METHODOLOGY
Patients in the no test scenario all enter the model at A, while patients in the test scenario enter the model at either A or B dependent upon test result.

Patients in the no test scenario all enter the model at A, while patients in the test scenario enter the model at either A or B dependent upon test result.
Human Herpesvirus 6 Reactivation in Drug-induced Hypersensitivity Syndrome and DRESS Validation Score  Yukiko Ushigome, MD, Yoko Kano, MD, Kazuhisa Hirahara,

Human Herpesvirus 6 Reactivation in Drug-induced Hypersensitivity Syndrome and DRESS Validation Score  Yukiko Ushigome, MD, Yoko Kano, MD, Kazuhisa Hirahara,
Yumi Aoyama and Tetsuo Shiohara

Yumi Aoyama and Tetsuo Shiohara
Figure 2 Underreporting by physicians of specific treatment-associated symptoms by physicians in the TORCH trial Figure 2 | Underreporting by physicians.

Figure 2 Underreporting by physicians of specific treatment-associated symptoms by physicians in the TORCH trial Figure 2 | Underreporting by physicians.
Figure 3 Connexins in cartilage

Figure 3 Connexins in cartilage
Figure 1 Historical evolution of the clinical classification and

Figure 1 Historical evolution of the clinical classification and
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Figure 1 Grip strength across the lifecourse

Figure 1 Grip strength across the lifecourse
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 1 Factors underlying metabolic alterations in osteoarthritis
Figure 1 Induction of immune tolerance

Figure 1 Induction of immune tolerance
Figure 2 Risk factors for sarcopenia

Figure 2 Risk factors for sarcopenia
Figure 3 Microanatomical changes in enthesitis

Figure 3 Microanatomical changes in enthesitis

Similar presentations

Ads by Google